Ausgabe 3/2005
Inhalt (7 Artikel)
Pharmacokinetic Considerations in the Treatment of Tuberculosis in Patients with Renal Failure
Vincent Launay-Vacher, Hassane Izzedine, Gilbert Deray
Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT1B/1D Receptor Agonist for the Treatment of Migraine
Janet D. McEnroe, Joseph C. Fleishaker
Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye
Diane D.-S. Tang-Liu, Andrew Acheampong
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Shufeng Zhou, Sui Yung Chan, Boon Cher Goh, Eli Chan, Wei Duan, Min Huang, Howard L. McLeod
Pharmacokinetic/Pharmacodynamic Evaluation of Antimicrobial Treatments of Orofacial Odontogenic Infections
Arantxa Isla, Andrés Canut, Alicia R. Gascón, Alicia Labora, Bruno Ardanza-Trevijano, Maria Ángelés Solinís, Jose Luis Pedraz
Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia
Jun Shi, Marc Pfister, Stephen G. Jenkins, Sunny Chapel, Jeffrey S. Barrett, Ruedi E. Port, Dan Howard